Ai-driven emulsifier chemistry optimization for improved ice cream quality
This solution leverages AI and molecular simulations to optimize emulsifier chemistry in ice cream, enhancing texture and quality. It uses graph convolutional neural networks to predict and improve key properties, aiming to revolutionize ice cream manufacturing.
Overview
This innovative approach employs advanced AI techniques and molecular simulations to revolutionize the way emulsifiers are used in ice cream production, specifically targeting improvements in texture and overall quality. By integrating graph convolutional neural networks with molecular graph representations, the solution predicts key parameters such as viscosity, elasticity, and fat droplet size, essential for enhancing ice cream texture. This generative and simulation-based workflow aims to reduce trial-and-error in formulation, offering a data-driven path to optimal ice cream quality.
Technical specifications
- Graph convolutional neural networks are used to correlate emulsifier chemistry with physical properties such as viscosity and elasticity.
- Molecular simulations evaluate the interfaces formed between emulsifiers and fat globules, ice crystals, and air, analyzing interfacial tension and stability.
- The system proposes new chemistries or concentrations to optimize texture metrics, potentially leading to targeted, low-cost formulation improvements.
- Collaboration with UW–Madison researchers ensures data accuracy and relevance, leveraging their expertise in dairy science.
Technology readiness level
This technology is currently at TRL 2, indicating that its fundamental principles have been observed and reported. Further validation and development are ongoing to advance its readiness for commercial application.
About University of Wisconsin, Madison
The University of Wisconsin–Madison is the state’s flagship public research university, a comprehensive institution with a large research enterprise and broad disciplinary breadth. Industry engages through shared instrumentation, pilot‑scale testbeds, and co-located core facilities that support prototyping and scale-up. An affiliated research and technology park hosts startups and corporate R&D, while integration with a major hospital system enables clinical translation; a statewide extension network connects campus advances to companies and communities across Wisconsin. Research is sustained by competitive federal funding from agencies such as NIH, NSF, DOE, USDA, and DoD, alongside state and industry partnerships. Dedicated commercialization support—through an affiliated foundation and campus offices—provides IP management, licensing, startup mentoring, and flexible, industry-friendly agreements.
delivered to your inbox.